From: Improved survival among colon cancer patients with increased differentially expressed pathways
 |  | Total population | Group A 1 | Group B | |||
---|---|---|---|---|---|---|---|
 |  | n | % | n | % | n | % |
Sex | Male | 94 | 53.7 | 18 | 48.6 | 14 | 34.1 |
 | Female | 81 | 46.3 | 19 | 51.4 | 27 | 65.9 |
Center | Kaiser | 106 | 60.6 | 22 | 59.5 | 23 | 56.1 |
 | Utah | 69 | 39.4 | 15 | 40.5 | 18 | 43.9 |
Site | Proximal | 78 | 47.9 | 16 | 45.7 | 21 | 53.8 |
 | Distal | 85 | 52.2 | 19 | 54.3 | 18 | 46.2 |
Vital status | Alive | 104 | 59.4 | 15 | 40.5 | 24 | 58.5 |
 | CRC death | 39 | 22.3 | 22 | 59.5 | 17 | 41.5 |
 | Other death | 17 | 9.7 |  |  |  |  |
 | Unknown | 15 | 8.6 |  |  |  |  |
AJCC stage | 1 | 40 | 23.0 | 6 | 16.2 | 8 | 19.5 |
 | 2 | 56 | 32.2 | 9 | 24.3 | 14 | 34.1 |
 | 3 | 57 | 32.8 | 15 | 40.5 | 9 | 22.0 |
 | 4 | 21 | 12.1 | 7 | 18.9 | 10 | 24.4 |
TP53 | Non-mutated | 98 | 56.0 | 22 | 59.5 | 26 | 63.4 |
 | Mutated | 77 | 44.0 | 15 | 40.5 | 15 | 36.6 |
KRAS | Non-mutated | 127 | 72.6 | 26 | 70.3 | 31 | 75.6 |
 | Mutated | 48 | 27.4 | 11 | 29.7 | 10 | 24.4 |
MSI | Stable | 143 | 81.7 | 30 | 81.1 | 33 | 80.5 |
 | Unstable | 32 | 18.3 | 7 | 18.9 | 8 | 19.5 |
CIMP | Low | 130 | 74.3 | 27 | 73.0 | 27 | 65.9 |
 | High | 45 | 25.7 | 10 | 27.0 | 14 | 34.1 |
 |  | Mean | STD | Mean | STD | Mean | STD |
Age | Â | 65.2 | 10.2 | 64.8 | 10.9 | 63.2 | 11.3 |